Baxter International (BAX) Non-Current Debt (2009 - 2026)
Baxter International's (BAX) quarterly Non-Current Debt came in at $8.6 billion in Q2 2026, down 9.24% year-over-year from $9.5 billion in Q2 2025, and little changed quarter-over-quarter from $8.6 billion in Q1 2026.
Analysis
Baxter International (BAX) Non-Current Debt (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Non-Current Debt for 18 consecutive years, with $8.6 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 9.24% year-over-year to $8.6 billion in Q2 2026; TTM through Jun 2026 was $8.6 billion, a 9.24% decrease from a year earlier, with the FY2025 full-year figure at $9.5 billion, down 8.69% from the prior year.
- Non-Current Debt was $8.6 billion for Q2 2026 at Baxter International, roughly flat from $8.6 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $16.2 billion in Q3 2022 and troughed at $175.0 million in Q1 2022.
- A 5-year average of $10.2 billion and a median of $10.4 billion in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt jumped 8630.29% in 2023 and dropped 27.4% in 2024, its largest moves.
- Over 5 years, Non-Current Debt stood at $15.2 billion in 2022, then decreased by 27.2% to $11.1 billion in 2023, then slipped by 6.45% to $10.4 billion in 2024, then slipped by 8.69% to $9.5 billion in 2025, then dropped by 9.06% to $8.6 billion in 2026.
- The last three Non-Current Debt figures came in at $8.6 billion (Q2 2026), $8.6 billion (Q1 2026), and $9.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 13.51 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 12.55 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 202.90 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 8.62 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 370.86 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 22.64 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 7.24 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 336,991.00 |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 80,924.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 126,201.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.62 Bn |
| Mar 31, 2026 | 8.62 Bn |
| Dec 31, 2025 | 9.47 Bn |
| Sep 30, 2025 | 8.75 Bn |
| Jun 30, 2025 | 9.49 Bn |
| Mar 31, 2025 | 9.41 Bn |
| Dec 31, 2024 | 10.37 Bn |
| Sep 30, 2024 | 10.44 Bn |
| Jun 30, 2024 | 10.44 Bn |
| Mar 31, 2024 | 11.09 Bn |
| Dec 31, 2023 | 11.09 Bn |
| Sep 30, 2023 | 14.07 Bn |
| Jun 30, 2023 | 14.31 Bn |
| Mar 31, 2023 | 15.28 Bn |
| Dec 31, 2022 | 15.23 Bn |
| Sep 30, 2022 | 16.15 Bn |
| Jun 30, 2022 | 355.00 Mn |
| Mar 31, 2022 | 175.00 Mn |
| Dec 31, 2021 | 17.15 Bn |
| Dec 31, 2020 | 5.79 Bn |